Nomura Asset Management Co. Ltd. boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 7.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 66,604 shares of the semiconductor company’s stock after acquiring an additional 4,356 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Synopsys were worth $34,147,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Raiffeisen Bank International AG lifted its stake in shares of Synopsys by 5.9% in the 2nd quarter. Raiffeisen Bank International AG now owns 16,658 shares of the semiconductor company’s stock valued at $8,118,000 after purchasing an additional 926 shares during the last quarter. Symphony Financial Ltd. Co. raised its holdings in Synopsys by 4,780.9% during the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after buying an additional 39,395 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH lifted its position in Synopsys by 3.5% in the second quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 288,970 shares of the semiconductor company’s stock worth $148,149,000 after buying an additional 9,822 shares during the last quarter. Tortoise Investment Management LLC lifted its position in Synopsys by 55.6% in the second quarter. Tortoise Investment Management LLC now owns 84 shares of the semiconductor company’s stock worth $43,000 after buying an additional 30 shares during the last quarter. Finally, Kingsview Wealth Management LLC boosted its stake in Synopsys by 4.0% during the second quarter. Kingsview Wealth Management LLC now owns 751 shares of the semiconductor company’s stock worth $385,000 after buying an additional 29 shares during the period. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Price Performance
Synopsys stock opened at $383.82 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. The stock has a market cap of $71.29 billion, a price-to-earnings ratio of 30.13, a price-to-earnings-growth ratio of 5.02 and a beta of 1.10. The firm has a 50-day moving average of $446.18 and a two-hundred day moving average of $512.51. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on SNPS. JPMorgan Chase & Co. reduced their target price on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. Weiss Ratings reiterated a “hold (c)” rating on shares of Synopsys in a report on Wednesday, October 8th. Bank of America reissued an “underperform” rating and issued a $525.00 price objective (down previously from $625.00) on shares of Synopsys in a research note on Wednesday, September 10th. Morgan Stanley dropped their target price on Synopsys from $715.00 to $510.00 and set an “overweight” rating for the company in a research report on Thursday, September 11th. Finally, KeyCorp reduced their price target on Synopsys from $660.00 to $590.00 and set an “overweight” rating on the stock in a report on Wednesday, September 10th. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, Synopsys has an average rating of “Hold” and a consensus price target of $562.14.
View Our Latest Analysis on Synopsys
Insider Transactions at Synopsys
In other news, Director Robert G. Painter bought 350 shares of the stock in a transaction on Thursday, September 11th. The stock was acquired at an average cost of $425.44 per share, for a total transaction of $148,904.00. Following the acquisition, the director owned 2,291 shares of the company’s stock, valued at $974,683.04. This represents a 18.03% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $609.77, for a total value of $2,228,709.35. Following the transaction, the chief financial officer directly owned 15,317 shares in the company, valued at $9,339,847.09. The trade was a 19.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 30,894 shares of company stock valued at $16,760,783. Company insiders own 0.62% of the company’s stock.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- Stock Dividend Cuts Happen Are You Ready?
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
